Thank you for reading

Comment icon 0 Comments
The scribbler behind PhillyPharma is moving on to a new stage of life at our media company. Thank you for reading. All the best. Scribble... Read more

GSK executive: More voices make drug-healthcare cost debate different from 1990s

Comment icon 0 Comments
The ever-more public debate about the price of prescription drugs and healthcare overall is not the first such debate. But GlaxoSmithKline's... Read more

Lannett closes $1.23 billion deal to buy Kremers Urban Pharmaceuticals

Comment icon 0 Comments
Philadelphia-based drugmaker Lannett Company, Inc. said Friday that it closed its $1.23 billion purchase of Princeton-based Kremers Urban Pharmaceuticals... Read more

Congressional critics of high drug prices planning to do more

Comment icon 0 Comments
Congressional Democrats, who have grabbed headlines and started investigations about drug pricing, have launched a task force to address the... Read more

GSK chief Andrew Witty mum on rebuffing Pfizer, rah-rah on own R&D

Comment icon 0 Comments
GlaxoSmithKline CEO Andrew Witty declined to comment Tuesday morning when asked on a conference call with reporters if the London-based drugmaker... Read more

Shire to pay $5.9 billion for Dyax

Comment icon 0 Comments
Shire, PLC, said Monday it will pay about $5.9 billion to buy Dyax Corp., a Massachusetts-based company whose most prominent drug candidate... Read more

Drug wholesaler AmerisourceBergen says revenue reached nearly $136 billion

Comment icon 0 Comments
Drug wholesaler AmerisourceBergen, Pennslyvania's largest company by revenue, said its full-year sales increased from $119.57 billion in 2014... Read more

Philly’s Lannett pays $1.23 billion for Belgian drugmakers’ generics unit

Comment icon 0 Comments
Philadelphia drugmaker Lannett Company, Inc. said Wednesday it agreed to pay $1.23 billion for Kremers Urban Pharmaceuticals Inc., the U.S... Read more